Arrêt de service lundi 11 juillet de 12h30 à 13h : tous les sites du CCSD (HAL, Epiciences, SciencesConf, AureHAL) seront inaccessibles (branchement réseau à modifier)
Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Ultra-Fast Measurement of Metformin in the Clinical Setting Using Probe Elecrospray Ionization Mass Spectrometry (PESI-MS).

Abstract : Metformin is a treatment used for type 2 diabetes. Lactic acidosis (LA) is a frequent complication that can either be induced by or associated with elevated metformin plasma concentrations. When coupled with a mass spectrometry system (MS), the Probe Electrospray Ionization (PESI) method allows direct and rapid analysis of different types of matrices without pre-treatment. In this study we developed a PESI-MS method for the determination of metformin in plasma. We used a tandem mass spectrometer equipped with a PESI source in the reaction monitoring mode for the quantitation of metformin. Metformin-D6 was chosen as internal standard, following an isotope dilution approach. The method was fully validated with 6 concentration levels (0.5 to 50 mg/L). The matrix effect was evaluated for each level and the specificity was tested with a mix of potential co-medications. Using patient samples, the performance was compared with 2 classical LC-MS/MS and LC-DAD methods used in external labs. Sample preparation consisted in mixing 10\textmu L plasma in 1000\textmu L ethanol/ ammonium formate buffer including metformin-D6 at a fixed concentration of 5 mg/L. Total run time was 0.31 min. Isotope dilution gave satisfactory results of accuracy and precision (min-max: -12.1-15.8% and 1.0-17.1%, respectively). The matrix effect was fully corrected by the internal standard (bias < 1%). The specificity study also reported satisfactory results. Finally, in a representative group of 29 patients (55% with a concentration <5 mg/L, 38% with a concentration >5 mg/L and 7% not detected), we observed almost identical results when comparing LC-DAD and LC-MS/MS to PESI-MS (r2 > 0.99).We propose a specific, sensitive, accurate and ultra-fast solution for the measurement of metformin in patient plasma, with no sample preparation or calibration curve building. This could be helpful in a core Lab when rapid diagnosis of lactic acidosis is needed.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03686647
Contributeur : Louise DESSAIVRE Connectez-vous pour contacter le contributeur
Soumis le : jeudi 2 juin 2022 - 18:05:32
Dernière modification le : vendredi 3 juin 2022 - 03:32:53

Identifiants

Citation

Pauline Griffeuille, Souleiman El Balkhi, Sandra Bodeau, Fabien Lamoureux, Pierre Marquet, et al.. Ultra-Fast Measurement of Metformin in the Clinical Setting Using Probe Elecrospray Ionization Mass Spectrometry (PESI-MS).. Journal of analytical toxicology, 2022, pp.bkac034. ⟨10.1093/jat/bkac034⟩. ⟨hal-03686647⟩

Partager

Métriques

Consultations de la notice

0